We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

95 hedge funds and large institutions have $811M invested in Enfusion, Inc. in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,956% more call options, than puts

Call options by funds: $365K | Put options by funds: $9K

317% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 6

122% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 18

25% more funds holding

Funds holding: 7695 (+19)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

2% less capital invested

Capital invested by funds: $830M → $811M (-$19M)

Holders
95
Holders Change
+19
Holders Change %
+25%
% of All Funds
1.37%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
25
Increased
40
Reduced
18
Closed
6
Calls
$365K
Puts
$9K
Net Calls
+$356K
Net Calls Change
+$111K
Name Holding Trade Value Shares
Change
Change in
Stake
GAM
76
Gotham Asset Management
New York
$94.1K +$89.5K +10,171 New
HCA
77
Harbor Capital Advisors
Illinois
$90K +$85.7K +9,744 New
Zurich Cantonal Bank
78
Zurich Cantonal Bank
Switzerland
$62.3K
Allspring Global Investments
79
Allspring Global Investments
North Carolina
$44.1K +$42K +4,772 New
AIP
80
Ameritas Investment Partners
Nebraska
$35K
MLICM
81
Metropolitan Life Insurance Company (MetLife)
New York
$21.2K
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$20K -$79.4K -9,025 -80%
AB
83
Amalgamated Bank
New York
$12K -$31.8K -3,619 -73%
Osaic Holdings
84
Osaic Holdings
Arizona
$9.2K
SSG
85
Summit Securities Group
New York
$9K -$4.4K -500 -33%
TRCT
86
Tower Research Capital (TRC)
New York
$8.57K -$78.9K -8,968 -91%
Fidelity Investments
87
Fidelity Investments
Massachusetts
$8.36K +$968 +110 +14%
MA
88
MCF Advisors
Kentucky
$5.35K +$1.02K +116 +25%
MIFH
89
Migdal Insurance & Financial Holdings
Israel
$2K +$669 +76 +62%
CG
90
Cutler Group
California
$2K +$2.64K +300 New
C
91
Covestor
United Kingdom
$1K +$924 +105 +300%
GI
92
GAMMA Investing
California
$611 +$581 +66 New
AF
93
Allworth Financial
California
$463 +$440 +50 New
Nisa Investment Advisors
94
Nisa Investment Advisors
Missouri
$435 +$97 +11 +31%
AWM
95
Avior Wealth Management
Nebraska
$64 +$62 +7 New
RAM
96
Readystate Asset Management
Illinois
-$1.06M -108,813 Closed
WHP
97
Washington Harbour Partners
Virginia
-$981K -101,100 Closed
State of Wisconsin Investment Board
98
State of Wisconsin Investment Board
Wisconsin
-$482K -49,695 Closed
NYLIM
99
New York Life Investment Management
New York
-$321K -33,144 Closed
SPS
100
Susquehanna Portfolio Strategies
Pennsylvania
-$113K -11,623 Closed

ENFN Hedge Fund Activity: Q1 2024 in Review

95 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2024, worth a combined $811M — down 2.3% from $830M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ENFN positions and 6 closed out — a net gain of 19 holders — while 40 added to existing stakes and 18 trimmed.

The largest buyer was Lead Edge Capital Management, opening a new position worth an estimated $7.49M. The largest seller was Brown Capital Management, cutting an estimated $16.2M.

  • 95 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2024, up from 76 in Q4 2023.
  • Funds reported $811M of Enfusion, Inc. stock for Q1 2024, down 2.3% quarter-over-quarter.
  • 25 funds opened new Enfusion, Inc. positions in Q1 2024 and 6 closed out, a net change of +19 holders.
  • The largest Enfusion, Inc. buyer in Q1 2024 was Lead Edge Capital Management, an estimated $7.49M added.
  • The largest Enfusion, Inc. seller in Q1 2024 was Brown Capital Management, an estimated $16.2M sold.

Based on aggregated 13F filings for Q1 2024.